Variables (n = 25 ) | Training Set (n = 105 ) | Validation Set (n = 94 ) | ||||
---|---|---|---|---|---|---|
MP-related Hepatitis ( n = 55 ) | Non-Hepatitis (n = 50 ) | P | MP-related Hepatitis (n = 44 ) | Non-Hepatitis (n = 50 ) | P | |
Gender | ||||||
Male, n (%) | 28 (51.0) | 31 (62.0) | 0.253 | 20 (45.0) | 16 (32.0) | 0.181 |
Female, n (%) | 27 (49.0) | 19 (38.0) | 24 (55.0) | 34 (68.0) | ||
Anti-M.P IgM titera | ||||||
Low titer, n (%) | 35 (63.6) | 26(52.0) | 0.227 | 28 (63.6) | 25 (50.0) | 0.183 |
High titer, n (%) | 20 (36.4) | 24(48.0) | 16 (36.4) | 25 (50.0) | ||
Age, median (IQR) (Months) | 50 (18,84) | 50.5 (38.8,70.0) | 0.717 | 64.5 (25.5,96.0) | 60.5(41.0,80.0) | 0.883 |
WBC, median (IQR) (^109/L) | 8.70 (6.4,10.7) | 7.35 (6.48,9.13) | 0.105 | 8.4 (6.7,11.3) | 8.2 (6.18,9.38) | 0.319 |
Neutrophil proportion (%) | 53.46 ± 16.41 | 52.68 ± 16.78 | 0.810 | 52.26 ± 17.33 | 57.88 ± 13.06 | 0.083 |
Lymphocyte proportion (%) | 38.00 ± 15.80 | 39.23 ± 16.31 | 0.695 | 38.69 ± 16.38 | 33.80 ± 13.03 | 0.111 |
MO proportion (IQR) (%) | 6.90 (5.9,8.2) | 5.90 (4.9.7.90) | 0.139 | 6.5 (5.25,8.28) | 6.7 (4.83,7.9) | 0.471 |
Eosinophil proportion (IQR) (%) | 0.50 (0.2,0.9) | 0.60 (0.2,1.33) | 0.203 | 0.75 (0.33,1.20) | 0.7 (0.20,1.13) | 0.276 |
Basophil proportion (IQR) (%) | 0.30 (0.20, 0.90) | 0.50 (0.30,1.00) | 0.075 | 0.4 (0.2,0.6) | 0.45 (0.3,0.7) | 0.118 |
Neutrophil, median (IQR) (^109/L) | 4.40 (3.00,6.00) | 4.00 (2.60,5.15) | 0.175 | 4.4 (2.79,5.8) | 4.25 (3.33,6.08) | 0.625 |
Lymphocyte, median (IQR) (^109/L) | 2.80 (1.70,4.90) | 2.95 (1.88,3.90) | 0.790 | 3.19 (2.5,4.41) | 2.8 (2.1,3.85) | 0.150 |
MO, median (IQR) (109/L) | 0.6 (0.5,0.8) | 0.4 (0.4,0.6) | 0.003* | 0.6 (0.4,0.87) | 0.4 (0.3,0.6) | 0.008* |
Eosinophil, median (IQR) (^109/L) | 0.01 (0.00,0.10) | 0.04 (0.00,0.10) | 0.791 | 0.1 (0.00, 0.10) | 0.06 (0.00,0.10) | 0.273 |
Basophil, median (IQR) (^109/L) | 0.00 (0.00,0.04) | 0.00 (0.00,0.10) | 0.262 | 0.00 (0.00,0.04) | 0.00 (0.00,0.10) | 0.681 |
RBC count (^1012/L) | 4.59 ± 0.41 | 4.52 ± 0.31 | 0.333 | 4.56 ± 0.42 | 4.59 ± 0.34 | 0.712 |
Hemoglobin (g/L) | 127.40 ± 10.68 | 125.62 ± 9.50 | 0.371 | 125.05 ± 12.92 | 128.40 ± 9.18 | 0.147 |
Hematokrit (%) | 37.88 ± 3.15 | 37.28 ± 2.63 | 0.295 | 37.39 ± 2.91 | 37.90 ± 2.54 | 0.365 |
MCV (fL) | 82.90 ± 5.03 | 82.55 ± 3.79 | 0.695 | 82.65 ± 4.43 | 82.19 ± 6.15 | 0.684 |
MCH, median (IQR) (pg) | 27.2 (26.35,28.70) | 27.8 (27.05,29.05) | 0.133 | 27.5 (26.48,28.28) | 27.9 (27.1,28.9) | 0.171 |
MCHC, median (IQR) (g/L) | 331 (324,344) | 335 (331,344) | 0.071 | 336 (329.25,341) | 338.5 (336,343) | 0.054 |
RDW, median (IQR) (%) | 12.0 (11.4,13.0) | 11.5 (11.1,12.1) | 0.002* | 11.9 (11.4,12.58) | 11.4(10.9,11.93) | 0.001* |
PLT (^109/L) | 290.13 ± 96.71 | 340.44 ± 89.79 | 0.007* | 297.95 ± 99.43 | 337.48 ± 86.91 | 0.043* |
PDW (fL) | 17.34 ± 0.91 | 16.80 ± 1.00 | 0.004* | 17.23 ± 0.80 | 16.83 ± 0.80 | 0.017* |
MPV (fL) | 5.35 ± 1.19 | 4.72 ± 0.99 | 0.004* | 5.09 ± 0.94 | 4.70 ± 0.82 | 0.035* |
PCT | 0.16 ± 0.09 | 0.16 ± 0.04 | 0.878 | 0.16 ± 0.05 | 0.15 ± 0.04 | 0.245 |